| Views | |
|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 145 |
| June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | |
|---|---|---|---|---|---|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 0 | 2 | 1 | 1 | 1 | 2 | 1 |
| Views | |
|---|---|
| 2021_Yu_etal.pdf | 37 |
